“…For medical devices, such emerging reports of using longer DNA fragments (Storsberg, 2018) gain traction and interest, although usage of this technology across platforms depends on further refinement. This aligns well with end-user approaches, such as sponsormediated approaches for authenticity (Su and Stolterman, 2016), or multi-factor authentication for cybersecurity (Sinha et al, 2019). That such sponsormediated and end-user approaches remain underutilized represents one of the greatest threats to patient safety and consumer confidence for the medical device industry.…”